SEC Form 4 · accession 0001193805-17-000282
ADMA BIOLOGICS, INC. · ADMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence P. Guiheen
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 8:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $5.00 | Feb 14, 2017 | A | 10,000 | A | — | Feb 14, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant.
- F2The option terminates on the earlier of (i) February 14, 2027 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer.